ERBB2 and cholangiocarcinoma: Preclinical studies have demonstrated that overexpression of HER2 in transgenic mouse models and orthotopic transplantation BDEneu models enhance the development of CCA, and provided consistent evidence of the oncogenic potential of EGFR [34].